Jane Huang

Insider Reports History

Entity
Individual
Location
C/O Mourant Ozannes Corporate Services, 94 Solaris Avenue, Camana Bay, Grand Cayman, Cayman Islands
Signature
/s/ Krishna Vaddi, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jane Huang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
BeiGene, Ltd. CMO, Hematology Ordinary Shares 160K $33.2M $207.72 Dec 14, 2021 Direct
Prelude Therapeutics Inc President, CMO Restricted Stock Unit 65.6K $311K $4.74 Jul 4, 2024 Direct
Prelude Therapeutics Inc President, CMO Common Stock 63.3K $127K $2.00 Oct 4, 2024 Direct
BeiGene, Ltd. CMO, Hematology Share Option (Right to Buy) 211K Dec 14, 2021 Direct
Prelude Therapeutics Inc President, CMO Employee Stock Option (right to buy) 175K Mar 1, 2024 Direct
Prelude Therapeutics Inc President, CMO Restricted Stock Unit 56.3K Oct 4, 2024 Direct
Protara Therapeutics, Inc. Director Stock Option (Right to Buy) 10K Jun 7, 2024 Direct
BeiGene, Ltd. CMO, Hematology American Depositary Shares 0 $180.50 Dec 14, 2021 Direct

Insider Reports Filed by Jane Huang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PRLD Prelude Therapeutics Inc Oct 4, 2024 3 -$6.7K 4 Oct 7, 2024 President, CMO
PRLD Prelude Therapeutics Inc Jul 4, 2024 3 -$12K 4 Jul 8, 2024 President, CMO
TARA Protara Therapeutics, Inc. Jun 7, 2024 1 $0 4 Jun 10, 2024 Director
PRLD Prelude Therapeutics Inc Apr 4, 2024 3 -$15.9K 4 Apr 8, 2024 President, CMO
PRLD Prelude Therapeutics Inc Mar 1, 2024 1 $0 4 Mar 4, 2024 President, CMO
PRLD Prelude Therapeutics Inc Jan 4, 2024 3 -$14.5K 4 Jan 8, 2024 President, CMO
PRLD Prelude Therapeutics Inc Oct 4, 2023 2 $0 4 Oct 6, 2023 President, CMO
PRLD Prelude Therapeutics Inc Jul 4, 2023 3 -$15.1K 4 Jul 6, 2023 President, CMO
TARA Protara Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
PRLD Prelude Therapeutics Inc Apr 4, 2023 3 -$81.3K 4 Apr 6, 2023 President, CMO
PRLD Prelude Therapeutics Inc Feb 7, 2023 1 $0 4 Feb 9, 2023 President, CMO
TARA Protara Therapeutics, Inc. Jun 8, 2022 1 $0 4 Jun 9, 2022 Director
PRLD Prelude Therapeutics Inc May 2, 2022 2 $0 4 May 4, 2022 President, CMO
PRLD Prelude Therapeutics Inc Apr 4, 2022 0 $0 3 Apr 6, 2022 President, CMO
BGNE BeiGene, Ltd. Dec 14, 2021 8 -$237K 4 Dec 16, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Nov 30, 2021 4 -$377K 4 Dec 2, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Nov 17, 2021 11 -$392K 4 Nov 19, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Oct 19, 2021 9 -$379K 4 Oct 21, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Sep 20, 2021 16 -$1.67M 4 Sep 22, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Sep 13, 2021 8 -$4.62M 4 Sep 15, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Aug 31, 2021 6 -$347K 4 Sep 2, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Jul 15, 2021 12 -$3.9M 4 Jul 19, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Jun 28, 2021 9 -$639K 4 Jun 30, 2021 CMO, Hematology
BGNE BeiGene, Ltd. Jun 16, 2021 3 -$153K 4 Jun 21, 2021 CMO, Hematology
TARA Protara Therapeutics, Inc. Jun 9, 2021 2 $0 4 Jun 10, 2021 Director
TARA Protara Therapeutics, Inc. Jun 9, 2021 0 $0 3 Jun 10, 2021 Director
BGNE BeiGene, Ltd. Jun 7, 2021 1 -$212K 4 Jun 9, 2021 CMO, Hematology
BGNE BeiGene, Ltd. May 28, 2021 11 -$686K 4 Jun 2, 2021 CMO, Hematology